Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJMI.L Regulatory News (JMI)

  • There is currently no data for JMI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

25 Mar 2020 17:31

RNS Number : 6272H
JPMorgan Smaller Cos IT PLC
25 March 2020
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

JPMORGAN SMALLER COMPANIES INVESTMENT TRUST PLC

UNAUDITED HALF YEAR RESULTS FOR THE SIX MONTHS ENDED31ST JANUARY 2020

Legal Entity Identifier: 549300PXALXKUMU9JM18

Information disclosed in accordance with DTR 4.2.2

 

CHAIRMAN'S STATEMENT

Performance and discount

In his outgoing statement my predecessor sagely observed that, despite challenging circumstances and market volatility, patient and selective investment in good companies should be rewarded over time. Therefore, I am pleased to report that your company has performed strongly over the six months period ended 31st January 2020. Whilst unfolding events have overtaken this good news, the Company's total return on net assets of +24.1% (with net dividends reinvested) significantly outperformed the benchmark, the Numis Small Cap plus AIM (ex Investment Companies) Index, which delivered +8.9% (in sterling terms). In addition, the total return to shareholders was +31.9% as the net asset return was enhanced by a narrowing of the discount over the period.

This outperformance relative to the benchmark index is explained in the Investment Managers' Report which provides a detailed commentary on the portfolio positioning and their current outlook for investing in the UK.

Loan Facility and Gearing

The Company has a highly flexible borrowing facility of £25 million in place with Scotiabank which expired on 4th October 2019 and was then renewed with Scotiabank for a further year. Under the terms of the agreement, the Company has the option to increase the facility commitment amount to £35.0 million in two increments of £5.0 million subject to certain conditions. In January 2020, the Board increased the amount drawn down on the facility to £30.0 million, therefore taking advantage of the accordion facility in place. Given the increase in the net asset value of the company, this gave the managers sufficient additional funding to continue to adjust the gearing tactically within the guidelines.

During a period of low interest rates, the use of gearing is an attractive way of amplifying the effect of rising markets, but inevitably increases the risk of loss if markets fall and volatility. The Company has maintained a fairly constant level of gearing, with the Board giving the Investment Managers flexibility to adjust the gearing tactically within guidelines. During the reporting period, the Company's gearing ranged from 6.1% to 10.2%, ending the half year at 9.8% geared. As at 24th March 2020 the Company's gearing had been reduced to 4.1%, with total borrowings of £30.0 million.

Share buybacks

During the six months to 31st January 2020 the Company repurchased 514,217 shares into Treasury for possible re-issue. These shares were acquired at an average discount of 15.2% enhancing net asset value per share by 0.254 pence. Our objective remains to reduce the volatility of the discount and our action during this period demonstrates the Board's aim to act in the best interests of shareholders by making purchases should supply and demand for shares become unbalanced.

Board succession

As noted in the previous Annual Report, I took over as Chairman of the Company following the retirement of Michael Quicke at the Annual General Meeting ('AGM') in November 2019.

Looking ahead, the Board's next priority is to appoint a successor to the Audit Committee Chairman, Andrew Robson, who will retire from the Board at the AGM in 2020. The Board has commenced the search for a suitable candidate.

Outlook

Since the end of the reporting period, markets have been substantially affected by the economic uncertainty caused by the spread of COVID-19. This has been exacerbated by a slump in the price of oil and the unprecedented measures taken to combat the virus. The progression of the pandemic and its economic fallout is highly uncertain and markets dislike uncertainty. Consequently, share prices have been under severe pressure globally and, a result, your company's net asset value has fallen by 37.9% to 199.6p as at 24th March 2020. The discount has also widened markedly. Globally, governments are taking extraordinary measures to try and limit the effect of the virus and the UK government and Bank of England have coordinated a series of significant initiatives. Whilst we await the progression and eventual economic outcome of these events, your managers' focus is, as ever, on assessing the quality and prospects for your investments. Current events not only present heightened risk but also opportunity and, given time, we hope to capitalise on these.

 

Andrew Impey

Chairman 

25th March 2020

 

INVESTMENT MANAGERS' REPORT

Performance and Market Background

2019 proved to be quite a year! While the global backdrop was one of continuing Middle Eastern agitation, ongoing (although slowly de-escalating) trade wars between China and the USA, and slowing global growth notably in Europe, caused by those trade wars, the main story for the UK stockmarket was all political. The first half of the financial year saw a new Prime Minister in situ, followed by the 31st October Brexit cliff-hanger, stalemate in Parliament, and then the December 2019 election. The outcome of the Election with its decisive victory and significant majority for the Conservatives, and the disappearance of the risk associated with a Corbyn-led Labour government, provided a level of certainty to UK politics that had been lacking for several years.

Against this backdrop, the UK small and mid cap indices performed very strongly. The Numis Smaller Companies plus AIM (ex Investment Companies) Index was up 8.9% over the six months. Your Company outperformed this significantly and produced a total return on net asset value of 24.1%. The decisive Conservative victory in the Election ended the political impasse and removed a significant degree of uncertainty over Brexit. This led to a sharp narrowing of the discount, leading to a share price total return of 31.9%

Portfolio

The strong outperformance of your Company over the first half of the financial year was broad-based. Many of our long-held positions produced very strong returns, among them Games Workshop, Judges Scientific and Avon Rubber. Other notable contributors included Dunelm, which we bought at the start of 2019, and Team 17, purchased at IPO in 2018. The only notable detractor from performance was not owning Frasers (the re-named Sports Direct).

We made a number of changes to the portfolio in the period. We exited two bid stocks, EI Group and Eland, some mining companies such as Ferrexpo and Hochschild, and sold Marstons, Fevertree and Vitec. The money was re-invested into a range of new businesses, both domestic and international, including CVS (a veterinary company), Bank of Georgia and an IPO, Pebble Group (a supplier of promotional merchandise). As we drew closer to the UK Election, and the outcome became more clear, we also added to a number of our more domestically focussed holdings. Post the Election, we increased this tilt further, and at the end of January we had positioned the portfolio to have a 10% overweight exposure to the UK relative to our index. The last time we had any notable overweight exposure to the UK versus International companies was prior to the Referendum in 2016.

Outlook

Post the Election and Parliamentary approval of a withdrawal agreement from the EU, we believe the political outlook for the UK is clearer than it has been for several years. We now have a pro growth, pro investment Government in place and have already seen Government spending accelerating at its fastest pace in 15 years. The recent Budget confirmed this. Low interest rates, low inflation and very low unemployment all add to the more positive picture.

There are two caveats. First, this positive view is dependent on the outcome of the EU withdrawal negotiations this year, and also the progress of trade talks with the USA, Japan and other countries. Second, and clearly dominant, is the threat to the global economy from the coronavirus, COVID-19. If this pandemic is contained in a timely manner then, given the extraordinary measures of support we have seen from the Government, we would expect a very strong bounce back in markets, and the UK, and in particular the harder hit smaller companies, should participate. If, however, the rest of the world does not recover from the COVID-19 impact at the rate that China appears to have, then all markets, including the UK, will continue to struggle.

As discussed above, we repositioned the portfolio to benefit from the more positive outlook in the UK and at the end of the half year on 31st January 2020, we were 9.8% geared. As the impact of COVID-19 began to take effect, we have reduced our gearing level, in order to provide ourselves with firepower when we believe it is time to add to our holdings. Current valuations were supportive prior to the recent very sharp decline in stockmarkets, but clearly it is difficult if not impossible to foresee where earnings levels will turn out for this year. When the current situation, and companies' earnings, normalise, we believe valuation levels will look very attractive, but the timing is highly uncertain. Overall your Company holds a portfolio of high quality and strong cash-generating companies, many of which we expect to come out of the current situation with stronger market positions. As we have said before, our focus is on owning long term winners, and while there may of course be exceptions, we think that this testing time will prove this to be the case.

Georgina Brittain

Katen Patel

Investment Managers 

25th March 2020

 

INTERIM MANAGEMENT REPORT

The Company is required to make the following disclosures in its half year report:

Principal Risks and Uncertainties

During 2020, the emergence of the virus COVID-19 (coronavirus) has created significant uncertainty for markets, and therefore risk to the value of investments and volatility. Other than this, the principal risks and uncertainties faced by the Company have not changed significantly and fall into the following broad categories: corporate strategy; investment and performance; discount; smaller company investment; political (including Brexit) and economic; investment management team; market; accounting, legal and regulatory; corporate governance and shareholder relations; operational and counterparty failure; cybercrime; and financial. Information on each of these areas is given in the Business Review within the Annual Report and Financial Statements for the year ended 31st July 2019.

Related Parties Transactions

During the first six months of the current financial year, no transactions with related parties have taken place which have materially affected the financial position or the performance of the Company during the period.

Going Concern

The Directors believe, having considered the Company's investment objectives, risk management policies, capital management policies and procedures, nature of the portfolio (including its liquidity) and expenditure projections, that the Company has adequate resources, an appropriate financial structure and suitable management arrangements in place to continue in operational existence for the foreseeable future and more specifically, that there are no material uncertainties pertaining to the Company that would prevent its ability to continue in such operational existence for at least twelve months from the date of the approval of this half year financial report. For these reasons, they consider there is reasonable evidence to continue to adopt the going concern basis in preparing the accounts.

Directors' Responsibilities

The Board of Directors confirms that, to the best of its knowledge:

(i) the condensed set of financial statements contained within the half yearly financial report has been prepared in accordance with FRS 104 'Interim Financial Reporting' and gives a true and fair view of the state of affairs of the Company and of the assets, liabilities, financial position and net return of the Company, as at 31st January 2019, as required by the UK Listing Authority Disclosure and Transparency Rules 4.2.4R; and

(ii) the interim management report includes a fair review of the information required by 4.2.7R and 4.2.8R of the UK Listing Authority Disclosure and Transparency Rules.

In order to provide these confirmations, and in preparing these financial statements, the Directors are required to:

• select suitable accounting policies and then apply them consistently;

• make judgements and accounting estimates that are reasonable and prudent;

• state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

• prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business;

and the Directors confirm that they have done so.

 

For and on behalf of the Board

Andrew Impey

Chairman

25th March 2020

 

 

 

STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED 31ST JANUARY 2020

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

31st January 2020

31st January 2019

31st July 2019

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Gains/(losses) on investments held at fair value through profit or loss

-

46,515

46,515

-

(37,967)

(37,967)

-

 (15,909)

(15,909)

Net foreign currency gains/(losses)

-

10

10

-

5

5

-

(4)

(4)

Income from investments

3,281

-

3,281

3,043

-

3,043

 6,376

-

6,376

Interest receivable and similar income

21

-

21

39

-

39

71

-

 71

Gross return/(loss)

3,302

46,525

49,827

3,082

(37,962)

(34,880)

 6,447

 (15,913)

 (9,466)

Management fee

(265)

(618)

(883)

(272)

 (633)

(905)

 (534)

 (1,245)

 (1,779)

Other administrative expenses

(210)

-

(210)

 (225)

-

(225)

(441)

-

(441)

Net return/(loss) before finance costs and taxation

2,827

45,907

48,734

2,585

(38,595)

(36,010)

 5,472

(17,158)

(11,686)

Finance costs

(32)

(74)

(106)

(57)

(133)

(190)

(166)

(387)

(553)

Net return/(loss) before taxation

2,795

45,833

48,628

2,528

(38,728)

(36,200)

 5,306

(17,545)

(12,239)

Taxation

(19)

-

(19)

 (40)

-

(40)

 (268)

-

(268)

Net return/(loss) after taxation

2,776

45,833

48,609

2,488

(38,728)

(36,240)

 5,038

(17,545)

(12,507)

Return/(loss) per share (note 3)

3.55p

58.65p

62.20p

3.12p

(48.63)p

(45.51)p

6.33p

(22.05)p

(15.72)p

 

All revenue and capital items in the above statement derive from continuing operations. No operations were acquired or discontinued in the period.

The 'Total' column of this statement is the profit and loss account of the Company and the 'Revenue' and 'Capital' columns represent supplementary information prepared under guidance issued by the Association of Investment Companies.

The net return after taxation represents the profit for the period and also the total comprehensive income.

 

 

 

 

 

 

 

 

 

STATEMENT OF CHANGES IN EQUITY

for the six months ended 31st january 2020

Called up

Capital

share

Share

redemption

Capital

Revenue

capital

premium

reserve

reserves

reserve

Total

£'000

£'000

£'000

£'000

£'000

£'000

Six months ended 31st January 2020 (Unaudited)

At 31st July 2019

3,981

25,895

 2,903

167,440

7,521

207,740

Repurchase of shares into Treasury

-

-

-

(1,142)

-

(1,142)

Net return on ordinary activities

-

-

-

45,833

2,776

48,609

Dividend paid in the period (note 4)

-

-

-

-

(4,293)

(4,293)

At 31st January 2020

3,981

25,895

2,903

212,131

6,004

250,914

Six months ended 31st January 2019 (Unaudited)

At 31st July 2018

3,985

25,895

2,899

187,547

6,782

227,108

Repurchase and cancellation of the Company's

own shares

(4)

-

4

(190)

-

(190)

Net (loss)/return on ordinary activities

-

-

-

(38,728)

2,488

(36,240)

Dividend paid in the period (note 4)

-

-

-

-

(4,299)

(4,299)

At 31st January 2019

3,981

25,895

2,903

148,629

 4,971

 186,379

Year ended 31st July 2019 (Audited)

At 31st July 2018

3,985

25,895

 2,899

187,547

6,782

227,108

Repurchase and cancellation of the

Company's own shares

(4)

-

4

(190)

-

(190)

Repurchase of shares into Treasury

-

-

 -

 (2,354)

-

 (2,354)

Costs relating to sub-division of shares

-

-

 -

(18)

-

(18)

Net (loss)/return

-

-

 -

(17,545)

5,038

(12,507)

Dividend paid in the year (note 4)

-

-

 -

-

 (4,299)

 (4,299)

At 31st July 2019

3,981

25,895

 2,903

167,440

7,521

207,740



 

 

 

 

STATEMENT OF FINANCIAL POSITION

at 31st january 2020

(Unaudited)

(Unaudited)

(Audited)

31st January 2020

31st January 2019

31st July 2019

£'000

£'000

£'000

Fixed assets

Investments held at fair value through profit or loss

275,392

197,392

225,773

Current assets

Debtors

1,014

1,689

2,489

Cash and cash equivalents

5,775

11,552

5,589

6,789

13,241

8,078

Current liabilities

Creditors: amounts falling due within one year

(31,267)

(24,254)

(26,111)

Net current liabilities

(24,478)

(11,013)

(18,033)

Total assets less current liabilities

250,914

186,379

207,740

Net assets

250,914

186,379

207,740

Capital and reserves

Called up share capital

3,981

3,981

3,981

Share premium

25,895

25,895

25,895

Capital redemption reserve

2,903

2,903

2,903

Capital reserves

212,131

148,629

167,440

Revenue reserve

6,004

4,971

7,521

Total shareholders' funds

250,914

186,379

207,740

Net asset value per share (note 5)

321.5p

234.1p

264.4p

 

 

 

 

 

 

 

STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED 31ST JANUARY 2020

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

31st January 2020

31st January 2019

31st July 2019

£'000

£'000

£'000

Net cash outflow from operations before dividends and

interest

(1,138)

(1,164)

(2,264)

Dividends received

3,048

3,008

6,079

Interest received

38

51

119

Interest paid

(166)

(186)

 (355)

Net cash inflow from operating activities

1,782

1,709

3,579

Purchases of investments

(53,339)

(45,975)

(104,183)

Sales of investments

51,243

59,490

110,307

Net cash (outflow)/inflow from investing activities

(2,096)

13,515

6,124

Dividend paid

(4,293)

(4,299)

(4,299)

Repurchase and cancellation of the Company's own shares

-

(190)

 (190)

Repurchase of shares into Treasury

(1,171)

-

 (2,325)

Costs relating to sub-division of shares

-

-

(18)

Fees in relation to aborted CULS issue

(33)

-

(99)

Repayment of bank loans

(4,000)

(3,000)

 (6,000)

Drawdown of bank loan

10,000

-

5,000

Loan renewal fees

(3)

-

-

Net cash inflow/(outflow) from financing activities

500

(7,489)

(7,931)

Increase in cash and cash equivalents

186

7,735

1,772

Cash and cash equivalents at start of period

5,589

3,817

3,817

Cash and cash equivalents at end of period

5,775

11,552

5,589

Increase in cash and cash equivalents

186

7,735

1,772

Cash and cash equivalents consist of:

Cash and short term deposits

253

286

722

Cash held in JPMorgan Sterling Liquidity Fund

5,522

11,266

4,867

Total

5,775

11,552

5,589

 

RECONCILIATION OF NET DEBT

 

As at

31st July 2019

£'000

Cash flows

£'000

Other

non-cash charges

£'000

As at

31st January 2020

£'000

Cash and cash equivalents

Cash

722

(480)

11

253

Cash equivalents

4,867

655

-

5,522

5,589

175

11

5,775

Borrowings

Debt due within one year

(24,000)

(6,000)

-

(30,000)

(24,000)

(6,000)

-

(30,000)

Total

(18,411)

(5,825)

11

(24,225)

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED 31ST JANUARY 2020

1. Financial statements

The information contained within the financial statements in this half year report has not been audited or reviewed by the Company's auditors.

The figures and financial information for the year ended 31st July 2019 are extracted from the latest published financial statements of the Company and do not constitute statutory accounts for that year. Those financial statements have been delivered to the Registrar of Companies and including the report of the auditors which was unqualified and did not contain a statement under either section 498(2) or 498(3) of the Companies Act 2006.

2. Accounting policies

The financial statements have been prepared in accordance with the Companies Act 2006, FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' of the United Kingdom Generally Accepted Accounting Practice ('UK GAAP') and with the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' (the revised 'SORP') issued by the Association of Investment Companies in October 2019.

FRS 104, 'Interim Financial Reporting', issued by the Financial Reporting Council ('FRC') in March 2015 has been applied in preparing this condensed set of financial statements for the six months ended 31st January 2020.

All of the Company's operations are of a continuing nature.

The accounting policies applied to this condensed set of financial statements are consistent with those applied in the financial statements for the year ended 31st July 2019.

3. Return/(loss) per share

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

31st January 2020

31st January 2019

31st July 2019

£'000

£'000

£'000

Return per share is based on the following:

Revenue return

2,776

2,488

5,038

Capital return/(loss)

45,833

(38,728)

(17,545)

Total return/(loss)

48,609

(36,240)

(12,507)

Weighted average number of shares in issue

78,152,078

79,635,219

 79,561,385

Revenue return per share

3.55p

3.12p

6.33p

Capital return/(loss) per share

58.65p

(48.63)p

(22.05)p

Total return/(loss) per share

62.20p

(45.51)p

(15.72)p

 

4. Dividend paid

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

31st January 2020

31st January 2019

31st July 2019

£'000

£'000

£'000

2019 final dividend of 5.5p (2018: 5.4p1)

4,293

4,299

 4,299

1 The dividend rate has been restated following the sub-division of each existing ordinary share of 25p into 5p each on 30th November 2018.

All dividends paid in the period have been funded from the revenue reserve.

No interim dividend has been declared in respect of the six months ended 31st January 2020 (2019: nil).

 

5. Net asset value per share

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

31st January 2020

31st January 2019

31st July 2019

Net assets (£'000)

250,914

186,379

207,740

Number of shares in issue

78,051,669

79,611,410

 78,565,886

Net asset value per share

321.5p

234.1p

264.4p

 

25th March 2020

For further information, please contact:

Lucy Dina

For and on behalf of

JPMorgan Funds Limited

020 7742 4000

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

JPMORGAN FUNDS LIMITED

ENDS

A copy of the half year will be submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM

The half year will also shortly be available on the Company's website at www.jpmsmallercompanies.co.uk where up to date information on the Company, including daily NAV and share prices, factsheets and portfolio information can also be found.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR BRGDXIDDDGGU
Date   Source Headline
28th Feb 202412:48 pmRNSChange of Name
28th Feb 202410:58 amRNSNet Asset Value(s)
27th Feb 20246:00 pmRNSJPMorgan UK Smaller Companies Investment Trust
27th Feb 20242:38 pmRNSResults of the Scheme and Issue of Scheme Shares
27th Feb 202411:06 amRNSNet Asset Value(s)
26th Feb 202412:23 pmRNSGearing Announcement
26th Feb 202411:12 amRNSNet Asset Value(s)
23rd Feb 202411:04 amRNSNet Asset Value(s)
22nd Feb 202410:36 amRNSNet Asset Value(s)
21st Feb 202410:53 amRNSNet Asset Value(s)
20th Feb 202410:27 amRNSNet Asset Value(s)
19th Feb 202411:47 amRNSGearing Announcement
19th Feb 202411:15 amRNSNet Asset Value(s)
16th Feb 202410:51 amRNSNet Asset Value(s)
15th Feb 20243:37 pmRNSNet Asset Value(s)
14th Feb 202411:26 amRNSNet Asset Value(s)
13th Feb 202411:22 amRNSNet Asset Value(s)
9th Feb 202410:27 amRNSNet Asset Value(s)
8th Feb 202411:07 amRNSNet Asset Value(s)
7th Feb 202411:15 amRNSNet Asset Value(s)
6th Feb 202410:42 amRNSNet Asset Value(s)
5th Feb 202411:45 amRNSGearing Announcement
5th Feb 202410:36 amRNSNet Asset Value(s)
2nd Feb 202411:53 amRNSNet Asset Value(s)
1st Feb 20244:12 pmRNSClosed Period Notification
1st Feb 202412:16 pmRNSNet Asset Value(s)
31st Jan 202411:10 amRNSNet Asset Value(s)
30th Jan 202411:21 amRNSNet Asset Value(s)
30th Jan 20247:00 amRNSKepler Trust Intelligence: New Research
29th Jan 202411:45 amRNSGearing Announcement
29th Jan 202411:07 amRNSNet Asset Value(s)
26th Jan 202410:53 amRNSNet Asset Value(s)
25th Jan 202410:49 amRNSNet Asset Value(s)
24th Jan 202410:54 amRNSNet Asset Value(s)
23rd Jan 20244:52 pmRNSPre-Completion Dividend Declaration
23rd Jan 202412:33 pmRNSPublication of Prospectus and Circular
23rd Jan 202411:30 amRNSNet Asset Value(s)
22nd Jan 202412:24 pmRNSGearing Announcement
22nd Jan 202411:11 amRNSNet Asset Value(s)
19th Jan 202411:16 amRNSNet Asset Value(s)
18th Jan 202410:45 amRNSNet Asset Value(s)
17th Jan 202410:37 amRNSNet Asset Value(s)
16th Jan 202410:46 amRNSNet Asset Value(s)
15th Jan 202412:12 pmRNSGearing Announcement
15th Jan 202411:07 amRNSNet Asset Value(s)
12th Jan 202411:04 amRNSNet Asset Value(s)
11th Jan 202410:45 amRNSNet Asset Value(s)
10th Jan 202410:42 amRNSNet Asset Value(s)
10th Jan 202410:27 amRNSTen Largest Investments
9th Jan 20243:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.